Dimensional Fund Advisors
SOPH icon

Dimensional Fund Advisors’s SOPHiA GENETICS SOPH Stock Holding History

Dimensional Fund Advisors’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-31,332
Closed -$148K – 3313
2025
Q3 		$148K Buy
31,332
+6,205
+25% +$21.3K ﹤0.01% 3155
2025
Q2 		$77.9K Hold
25,127
– – ﹤0.01% 3204
2025
Q1 		$83.3K Buy
25,127
+3,508
+16% +$12.3K ﹤0.01% 3220
2024
Q4 		$67.6K Buy
21,619
+4,115
+24% +$14K ﹤0.01% 3270
2024
Q3 		$63.9K Buy
17,504
+5,150
+42% +$20.9K ﹤0.01% 3274
2024
Q2 		$56.8K Hold
12,354
– – ﹤0.01% 3301
2024
Q1 		$60.9K Buy
+12,354
New +$59.7K ﹤0.01% 3319

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Dimensional Fund Advisors's SOPH Position: Q4 2025 in Review

Dimensional Fund Advisors sold out of SOPHiA GENETICS (SOPH) in Q4 2025, closing a stake of 31,332 shares — an estimated $148K sold.

Dimensional Fund Advisors first reported a position in SOPH in Q1 2024 and held it in 7 quarters. The position peaked at $148K in Q3 2025. 42 funds tracked by Wall St. Rank hold SOPH as of Q4 2025.

  • Dimensional Fund Advisors reported no remaining SOPHiA GENETICS position as of Q4 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 31,332 SOPHiA GENETICS shares in Q4 2025, an estimated $148K.
  • Dimensional Fund Advisors first reported a position in SOPHiA GENETICS in Q1 2024 and held it in 7 quarters.
  • Dimensional Fund Advisors's SOPHiA GENETICS position peaked at $148K in Q3 2025.
  • 42 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q4 2025.

Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.